{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:16Z","timestamp":1790610796823,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018607","name":"Henan Province Science and Technology Innovation Talent Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cllc.2024.02.001","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T23:11:08Z","timestamp":1707347468000},"page":"347-353.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Retrospective Real-World Study of Prognostic Factors Associated With EGFR Mutated Lung Cancer With Leptomeningeal Metastasis"],"prefix":"10.1016","volume":"25","author":[{"given":"Yingxi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cllc.2024.02.001_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cllc.2024.02.001_bib0002","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ctrv.2016.12.006","article-title":"Leptomeningeal carcinomatosis in non-small cell lung cancer patients: a continuing challenge in the personalized treatment era","volume":"53","author":"Remon","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.cllc.2024.02.001_bib0003","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejca.2015.12.021","article-title":"Leptomeningeal metastasis: clinical experience of 519 cases","volume":"56","author":"Hyun","year":"2016","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.cllc.2024.02.001_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12987-020-00196-2","article-title":"Choroid plexus and the blood-cerebrospinal fluid barrier in disease","volume":"17","author":"Sol\u00e1r","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.cllc.2024.02.001_bib0005","first-page":"33","article-title":"The role of the immune system in brain metastasis","volume":"10","author":"Leibold","year":"2019","journal-title":"Curr Neurobiol"},{"key":"10.1016\/j.cllc.2024.02.001_bib0006","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.lungcan.2019.03.015","article-title":"A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases","volume":"131","author":"Yin","year":"2019","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.cllc.2024.02.001_bib0007","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10147-014-0760-9","article-title":"Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations","volume":"20","author":"Iuchi","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2024.02.001_bib0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11060-017-2590-x","article-title":"High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases","volume":"135","author":"Ge","year":"2017","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.cllc.2024.02.001_bib0009","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/1078-0432.CCR-17-1582","article-title":"Cell-cycle and DNA-damage response pathway is involved in leptomeningeal metastasis of non-small cell lung cancer","volume":"24","author":"Fan","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.cllc.2024.02.001_bib0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11060-021-03924-2","article-title":"Leptomeningeal metastases: the future is now","volume":"156","author":"Lukas","year":"2022","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.cllc.2024.02.001_bib0011","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ca.23083","article-title":"Blood brain barrier: a review of its anatomy and physiology in health and disease","volume":"31","author":"Sharif","year":"2018","journal-title":"Clin Anat (New York, NY)"},{"issue":"2","key":"10.1016\/j.cllc.2024.02.001_bib0012","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11523-021-00794-6","article-title":"Osimertinib versus comparator EGFR TKI as first-line treatment for EGFR-mutated advanced NSCLC: FLAURA China, a randomized study","volume":"16","author":"Cheng","year":"2021","journal-title":"Target. Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2024.02.001_bib0013","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cllc.2024.02.001_bib0014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.lungcan.2015.05.023","article-title":"Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis","volume":"89","author":"Kuiper","year":"2015","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.cllc.2024.02.001_bib0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cllc.2013.12.009","article-title":"Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era","volume":"15","author":"Riess","year":"2014","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"10.1016\/j.cllc.2024.02.001_bib0016","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cllc.2024.02.001_bib0017","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1200\/JCO.19.00457","article-title":"Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: the BLOOM study","volume":"38","author":"Yang","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.cllc.2024.02.001_bib0018","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal metastases in patients with NSCLC with EGFR mutations","volume":"11","author":"Li","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"11","key":"10.1016\/j.cllc.2024.02.001_bib0019","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.jtho.2020.06.018","article-title":"Osimertinib improves overall survival in patients with EGFR-mutated NSCLC with leptomeningeal metastases regardless of T790M mutational status","volume":"15","author":"Lee","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2024.02.001_bib0020","article-title":"Osimertinib improves overall survival in patients with leptomeningeal metastases associated with EGFR-mutated non- small-cell lung cancer regardless of cerebrospinal fluid T790M mutational status","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evid-Based Complement Alternat Med: eCAM"},{"issue":"28","key":"10.1016\/j.cllc.2024.02.001_bib0021","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2217\/fon-2017-0302","article-title":"Bevacizumab in advanced lung cancer: state of the art","volume":"13","author":"Assoun","year":"2017","journal-title":"Future Oncol"},{"issue":"4","key":"10.1016\/j.cllc.2024.02.001_bib0022","first-page":"B4626","article-title":"Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema","volume":"60","author":"Nassehi","year":"2013","journal-title":"Dan Med J"},{"key":"10.1016\/j.cllc.2024.02.001_bib0023","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2016.07.008","article-title":"Erlotinib plus bevacizumab as an effective treatment for leptomeningeal metastases from EGFR mutation- positive non-small cell lung cancer","volume":"99","author":"Sakata","year":"2016","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.cllc.2024.02.001_bib0024","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.cllc.2024.02.001_bib0025","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/JTO.0000000000000669","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors for non-small-cell lung cancer patients with leptomeningeal carcinomatosis","volume":"10","author":"Liao","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2024.02.001_bib0026","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/JTO.0b013e3182773f21","article-title":"Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors","volume":"8","author":"Lee","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2024.02.001_bib0027","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13014-019-1376-z","article-title":"Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis","volume":"14","author":"Yan","year":"2019","journal-title":"Radiat Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730424000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730424000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:09:05Z","timestamp":1778616545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730424000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1525730424000123"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2024.02.001","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Retrospective Real-World Study of Prognostic Factors Associated With EGFR Mutated Lung Cancer With Leptomeningeal Metastasis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2024.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}